Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2022) - Comments
pubmed: 35803469  doi: 10.1016/j.ijid.2022.06.054  issn: 1201-9712  issn: 1878-3511 

Els Tobback, Sophie Degroote, Sabine Buysse, Liesbeth Delesie, Lucas Van Dooren, Sophie Vanherrewege, Cyril Barbezange, Veronik Hutse, Marta Romano, Isabelle Thomas, Elizaveta Padalko, Steven Callens, Marie-Angélique De Scheerder